Nursing, health informatics, and paramedic roles in prehospital management of overdose cases: Opioids and beyond
Keywords:
Opioids, overdose, paramedics, nursing, emergency medical services, pain management, opioid use disorderAbstract
Background: The opioid crisis has intensified, leading to numerous fatalities and heightened public health concerns regarding the management of overdose cases. The multifaceted challenges posed by opioid misuse and addiction necessitate a comprehensive approach involving paramedics, emergency medical services (EMS), and nursing professionals. Aim: This study aims to explore the roles of emergency medical services, health informatics, nursing and paramedic personnel in the prehospital management of overdose cases, focusing on opioids and other substances. Methods: A systematic review was conducted, synthesizing relevant literature on the prehospital management strategies employed by paramedics and nurses in cases of opioid overdose. Key interventions, risk factors, and outcomes were analyzed to identify best practices in the field. Results: Findings reveal that both nursing and paramedic roles are critical in addressing overdose cases. Paramedics provide immediate life-saving interventions, including the administration of naloxone, while nursing staff play a vital role in patient assessment and follow-up care. Collaborative efforts enhance patient outcomes and reduce the risk of future overdoses. Conclusion: The involvement of nursing and paramedic professionals in the prehospital management of overdose cases is essential in mitigating the opioid crisis.
Downloads
References
Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths—United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016;65:1445–1452. DOI: https://doi.org/10.15585/mmwr.mm655051e1
Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rep. 2016;65:1–49. DOI: https://doi.org/10.15585/mmwr.rr6501e1er
Lowes R. Message heard? Pain med prescribing down second year in row. Medscape. May 4, 2017. Available at: http://www.medscape.com/viewarticle/879514. Accessed September 18, 2017.
Lynch ME, Katz J. ‘One size fits all’ doesn’t fit when it comes to long-term opioid use for people with chronic pain. Canad J Pain. 2017;1:2–7. DOI: https://doi.org/10.1080/24740527.2017.1319733
Kroenke K, Cheville A. Management of chronic pain in the aftermath of the opioid backlash. JAMA. 2017;317:2365–2366. DOI: https://doi.org/10.1001/jama.2017.4884
Nahin RL. Estimates of pain prevalence and severity in adults: United States, 2012. J Pain. 2015;16:769–780. DOI: https://doi.org/10.1016/j.jpain.2015.05.002
Smith D, Wilkie R, Croft P, McBeth J. Pain and mortality in older adults: the influence of pain phenotype. Arthritis Care Res (Hoboken). 2017 [Epub ahead of print]. DOI: https://doi.org/10.1002/acr.23268
Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010CD006605. doi: 10.1002/14651858.CD006605.pub2. DOI: https://doi.org/10.1002/14651858.CD006605.pub2
Minozzi S, Amato L, Davoli M. Development of dependence following treatment with opioid analgesics for pain relief: a systematic review. Addiction. 2013;108:688–698. DOI: https://doi.org/10.1111/j.1360-0443.2012.04005.x
Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med. 2005;6:432–442. DOI: https://doi.org/10.1111/j.1526-4637.2005.00072.x
Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain. 2007;8:573–582. DOI: https://doi.org/10.1016/j.jpain.2007.02.432
Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156:569–576. DOI: https://doi.org/10.1097/01.j.pain.0000460357.01998.f1
Boscarino JA, Rukstalis MR, Hoffman SN, et al. Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis. 2011;30:185–194. DOI: https://doi.org/10.1080/10550887.2011.581961
Katz NP, Adams EH, Chilcoat H, et al. Challenges in the development of prescription opioid abuse-deterrent formulations. Clin J Pain. 2007;23:648–660. DOI: https://doi.org/10.1097/AJP.0b013e318125c5e8
Smith DE. The process addictions and the new ASAM definition of addiction. J Psychoactive Drugs. 2012;44:1–4. DOI: https://doi.org/10.1080/02791072.2012.662105
Saunders JB. Substance use and addictive disorders in DSM-5 and ICD 10 and the draft ICD 11. Curr Opin Psychiatry. 2017;30:227–237. DOI: https://doi.org/10.1097/YCO.0000000000000332
Institute of Medicine Committee on Advancing Pain Research, Care, and Education. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. 2011.Washington, DC: National Academies Press (US).
Carriere J, Darnall B, Kao M, Mackey S. (489) An examination of the roles of perceived injustice and pain acceptance on pain interference and pain intensity in patients with chronic pain: a Collaborative Health Outcomes Information Registry (CHOIR) Study. J Pain. 2016;17:S97. DOI: https://doi.org/10.1016/j.jpain.2016.01.296
Stanos S. Evolution of opioid risk management and review of the classwide REMS for extended-release/long-acting opioids. Phys Sportsmed. 2012;40:12–20. DOI: https://doi.org/10.3810/psm.2012.11.1975
Savage SR. What to do when pain and addiction coexist. J Fam Pract. 2013;62:S10–S16.
Atluri SL, Sudarshan G. Development of a screening tool to detect the risk of inappropriate prescription opioid use in patients with chronic pain. Pain Physician. 2004;7:333–338. DOI: https://doi.org/10.36076/ppj.2004/7/333
Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain. 2008;9:360–372. DOI: https://doi.org/10.1016/j.jpain.2007.11.014
Dunbar SA, Katz NP. Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases. J Pain Symptom Manage. 1996;11:163–171. DOI: https://doi.org/10.1016/0885-3924(95)00165-4
Friedman R, Li V, Mehrotra D. Treating pain patients at risk: evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Med. 2003;4:182–185. DOI: https://doi.org/10.1046/j.1526-4637.2003.03017.x
Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain. 2002;18(suppl 4):S28–S38. DOI: https://doi.org/10.1097/00002508-200207001-00004
Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage. 2006;32:287–293. DOI: https://doi.org/10.1016/j.jpainsymman.2006.03.010
Szalavitz M. The feds are about to stick it to pain patients in a big way. Vice. 2017.
Webster LR, Cochella S, Dasgupta N, et al. An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med. 2011;12Suppl 2S26–S35. DOI: https://doi.org/10.1111/j.1526-4637.2011.01134.x
Porucznik CA, Johnson EM, Sauer B, Crook J, Rolfs RT. Studying adverse events related to prescription opioids: the Utah experience. Pain Med. 2011;12Suppl 2S16–S25. DOI: https://doi.org/10.1111/j.1526-4637.2011.01133.x
Substance Abuse and Mental Health Services Administration: SAMHSA Opioid Overdose Prevention Toolkit. HHS Publication No. (SMA) 13–4742. 2013.Rockville, MD: Substance Abuse and Mental Health Services Administration.
Dasgupta N, Funk MJ, Proescholdbell S, Hirsch A, Ribisl KM, Marshall S. Cohort study of the impact of high-dose opioid analgesics on overdose mortality. Pain Med. 2016;17:85–98. DOI: https://doi.org/10.1111/pme.12907
Zedler BK, Saunders WB, Joyce AR, Vick CC, Murrelle EL. Validation of a screening risk index for serious prescription opioid-induced respiratory depression or overdose in a US Commercial Health Plan Claims Database. Pain Med. 2017 Mar 6 [Epub ahead of print]. DOI: https://doi.org/10.1093/pm/pnx009
Binswanger IA, Stern MF, Deyo RA, et al. Release from prison–a high risk of death for former inmates. N Engl J Med. 2007;356:157–165. DOI: https://doi.org/10.1056/NEJMsa064115
Anderson K. Death after treatment for heroin dependence. Pro Talk: a rehabs.com community.
Reisfield GM, Webster LR. Benzodiazepines in long-term opioid therapy. Pain Med. 2013;14:1441–1446. DOI: https://doi.org/10.1111/pme.12236
Zedler B, Xie L, Wang L, et al. Development of a risk index for serious prescription opioid-induced respiratory depression or overdose in Veterans’ Health Administration Patients. Pain Med. 2015;16:1566–1579. DOI: https://doi.org/10.1111/pme.12777
Ilgen MA, Kleinberg F, Ignacio RV, et al. Noncancer pain conditions and risk of suicide. JAMA Psychiatry. 2013;70:692–697. DOI: https://doi.org/10.1001/jamapsychiatry.2013.908
Stenager E, Christiansen E, Handberg G, Jensen B. Suicide attempts in chronic pain patients. A register-based study. Scand J Pain. 2013;5:4–7. DOI: https://doi.org/10.1016/j.sjpain.2013.09.001
Fishbain DA, Lewis JE, Gao J. The pain suicidality association: a narrative review. Pain Med. 2014;15:1835–1849. DOI: https://doi.org/10.1111/pme.12463
Hassett AL, Aquino JK, Ilgen MA. The risk of suicide mortality in chronic pain patients. Curr Pain Headache Rep. 2014;18:436. DOI: https://doi.org/10.1007/s11916-014-0436-1
Cheatle MD, Wasser T, Foster C, Olugbodi A, Bryan J. Prevalence of suicidal ideation in patients with chronic non-cancer pain referred to a behaviorally based pain program. Pain Physician. 2014;17:E359–E367. DOI: https://doi.org/10.36076/ppj.2014/17/E359
Rockett IR, Hobbs GR, Wu D, et al. Variable classification of drug-intoxication suicides across US States: a partial artifact of forensics? PLoS One. 2015;10:e0135296. DOI: https://doi.org/10.1371/journal.pone.0135296
Stone DM, Holland KM, Bartholow B, et al. Deciphering suicide and other manners of death associated with drug intoxication: a Centers for Disease Control and Prevention Consultation Meeting Summary. Am J Public Health. 2017;107:1233–1239. DOI: https://doi.org/10.2105/AJPH.2017.303863
Madadi P, Persaud N. Suicide by means of opioid overdose in patients with chronic pain. Curr Pain Headache Rep. 2014;18:460. DOI: https://doi.org/10.1007/s11916-014-0460-1
Cicero TJ, Kurtz SP, Surratt HL, et al. Multiple determinants of specific modes of prescription opioid diversion. J Drug Issues. 2011;41:283–304. DOI: https://doi.org/10.1177/002204261104100207
Walker MJ, Webster LR. Risk factors for drug diversion in a pain clinic patient population. J Opioid Manag. 2012;8:351–362. DOI: https://doi.org/10.5055/jom.2012.0135
Setnik B, Roland CL, Goli V, et al. Self-reports of prescription opioid abuse and diversion among recreational opioid users in a Canadian and a United States city. J Opioid Manag. 2015;11:463–473. DOI: https://doi.org/10.5055/jom.2015.0299
Jung B, Reidenberg MM. Physicians being deceived. Pain Med. 2007;8:433–437. DOI: https://doi.org/10.1111/j.1526-4637.2007.00315.x
Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10:131–146. DOI: https://doi.org/10.1016/j.jpain.2008.10.009
Rolfs RT, Johnson E, Williams NJ, Sundwall DN; Utah Department of Health. Utah clinical guidelines on prescribing opioids for treatment of pain. J Pain Palliat Care Pharmacother. 2010;24:219–235. DOI: https://doi.org/10.3109/15360288.2010.503265
Washington State Agency Medical Directors’ Group. Interagency Guideline on Prescribing Opioids for Pain2015.3rd ed. Olympia, WA: Agency Medical Directors’ Group.
Department of Veterans Affairs, Department of Defense. VA/DoD clinical practice guideline for opioid therapy for chronic pain. 2017.
Belgrade MJ, Schamber CD, Lindgren BR. The DIRE score: predicting outcomes of opioid prescribing for chronic pain. J Pain. 2006;7:671–681. DOI: https://doi.org/10.1016/j.jpain.2006.03.001
Butler SF, Budman SH, Fanciullo GJ, Jamison RN. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy. Clin J Pain. 2010;26:770–776. DOI: https://doi.org/10.1097/AJP.0b013e3181f195ba
Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the current opioid misuse measure. Pain. 2007;130:144–156. DOI: https://doi.org/10.1016/j.pain.2007.01.014
Tang NK, Crane C. Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links. Psychol Med. 2006;36:575–586. DOI: https://doi.org/10.1017/S0033291705006859
Webster LR. Eight principles for safer opioid prescribing. Pain Med. 2013;14:959–961. DOI: https://doi.org/10.1111/pme.12194
American Academy of Pain Medicine. AAPM comments to the CDC on the proposed 2016 guideline for prescribing opioids for chronic pain. January 12, 2016. Available at: http://www.painmed.org/press/position-statements/. Accessed September 15, 2017.
Bahji, A., & Bajaj, N. (2018). Opioids on trial: a systematic review of interventions for the treatment and prevention of opioid overdose. Canadian Journal of Addiction, 9(1), 26-33. DOI: https://doi.org/10.1097/CXA.0000000000000013
Published
How to Cite
Issue
Section
Copyright (c) 2019 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
